Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukaemia
Authors:
Open Access
- 16 May 2021
- journal article
- research article
- Published by Wiley in European Journal of Haematology
- Vol. 107 (2) , 265-274
Abstract
In older patients with chronic myelomonocytic leukaemia (CMML) and limited life expectancy due to age and or comorbidities, it is particularly important to consider the risk of transformation for individualised treatment decisions. There is limited information on potential differences between younger and older CMML patients regarding the cumulative risk of transformation as well as haematological, molecular and biologic characteristics. We analysed data from the Austrian Biodatabase for CMML (ABCMML) to compare these parameters in 518 CMML patients. Categorisation of patients into 3 age‐related groups: P < .0001). The lower probability of transformation was associated with a lower percentage of blast cells in the peripheral blood (PB) of older patients. Furthermore, we provide a simple score based on age, PB blasts and platelet counts that allowed us to define subgroups of CMML patients with a different cumulative transformation risk, including a low‐risk group with a transformation risk of only 5%. Our findings may facilitate reasonable treatment decisions in elderly patients with CMML.Keywords
This publication has 33 references indexed in Scilit:
- Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemiaBlood, 2013
- Revised International Prognostic Scoring System for Myelodysplastic SyndromesBlood, 2012
- Cytogenetic risk stratification in chronic myelomonocytic leukemiaHaematologica, 2010
- Activity of decitabine, a hypomethylating agent, in chronic myelomonocytic leukemiaCancer, 2007
- Age and acute myeloid leukemiaBlood, 2006
- The World Health Organization (WHO) classification of the myeloid neoplasmsBlood, 2002
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- Interleukin 10 inhibits growth and granulocyte/macrophage colony-stimulating factor production in chronic myelomonocytic leukemia cells.Journal of Experimental Medicine, 1996
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982